Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.6K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.1K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.1K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

121
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
121
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

100
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
100
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

35.7K
VSEPR Theory for Determination of Electron Pair Geometries
35.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of healthy lifestyle with incident cardiovascular diseases in individuals with type 1 diabetes mellitus: a prospective cohort study.

Diabetology & metabolic syndrome·2026
Same author

Integrated anthropometric correlates of planned change-of-direction performance (T-test) in male badminton players: a partial least squares regression study.

Frontiers in physiology·2026
Same author

Concurrent control of natural and robotic limbs through a tactile-encoded brain-computer interface.

Nature communications·2026
Same author

Jasmonate, salicylate, and ethylene-responsive transcriptomics discovery in spikelets of three wheat genotypes reveals a rapid and conserved response for jasmonate signaling.

Plant signaling & behavior·2026
Same author

Assessing different Protein A resins' homodimer separation potentials through processing a two-antibody-containing artificial mixture.

Protein expression and purification·2026
Same author

Reply to "Letter to the editor: methodological considerations in the benchmarking of AI-based protein-aptamer complex prediction".

Briefings in bioinformatics·2026

Related Experiment Video

Updated: Sep 4, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

509

Multi-Objective Drug Design Based on Graph-Fragment Molecular Representation and Deep Evolutionary Learning.

Muhetaer Mukaidaisi1, Andrew Vu1, Karl Grantham1

  • 1Biomedical Data Science Laboratory, Department of Computer Science, Brock University, St. Catharines, ON, Canada.

Frontiers in Pharmacology
|July 21, 2022
PubMed
Summary

This study introduces an AI-driven approach for fragment-based drug design, optimizing molecules for better binding affinity and properties. The novel method enhances drug discovery efficiency by exploring vast chemical spaces.

Keywords:
deep evolutionary learningdrug designgraph fragmentationmulti-objective optimizationprotein-ligand binding affinityvariational autoencoder

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.0K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K

Related Experiment Videos

Last Updated: Sep 4, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

509
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.0K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K

Area of Science:

  • Computational chemistry and drug discovery.

Background:

  • Drug discovery involves navigating vast molecular spaces and considering complex pharmacological properties.
  • Fragment-based drug design (FBDD) offers a strategic approach to constrain search spaces and leverage active compounds.

Purpose of the Study:

  • To advance *in silico* drug design by integrating a graph fragmentation-based deep generative model with deep evolutionary learning.
  • To optimize molecules for large-scale, multi-objective drug design, considering binding affinity and physicochemical properties.

Main Methods:

  • Developed a novel method combining a graph fragmentation-based deep generative model with deep evolutionary learning.
  • Utilized protein-ligand binding affinity scores and other physicochemical properties as optimization objectives.

Main Results:

  • The proposed method successfully generated novel molecules.
  • Generated molecules exhibited improved property values and enhanced binding affinities compared to existing methods.

Conclusions:

  • The integrated AI approach significantly advances *in silico* drug design capabilities.
  • This method provides an effective strategy for discovering novel drug candidates with optimized properties and binding affinities.